Krishnan Krish S 的 Form 4 申報
Krystal Biotech, Inc.（KRYS），2025/7/11 申報
- 申報編號
- 0001298709-25-000007
- 申報時間
- 2025/7/11
- 交易日
- 2025/7/9-7/10
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $212.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Krishnan Krish SCIK 0001298709 | 董事、高階主管（總裁、執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/7/9 | Common Stock | S賣出處分 | −200 | $150.07F2 | −$30,014 | 1,532,856 | 直接 | |
| 2025/7/10 | Common Stock | S賣出處分 | −6,627 | $150.22F3 | −$995,507.94 | 1,526,229 | 直接 | |
| 2025/7/10 | Common Stock | S賣出處分 | −300 | $151.39F4 | −$45,417 | 1,525,929 | 直接 | |
| 2025/7/9 | Common Stock | S賣出處分 | −200 | $150.14F7 | −$30,028 | 1,463,511 | 間接 | |
| 2025/7/10 | Common Stock | S賣出處分 | −6,500 | $150.23F3 | −$976,495 | 1,457,011 | 間接 | |
| 2025/7/10 | Common Stock | S賣出處分 | −300 | $151.39F4 | −$45,417 | 1,456,711 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in two trades of 100 shares each at $150 and $150.14, respectively. The price reported above reflects the average sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades ranging from $150.00 to $150.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F4
The transaction was executed in three trades of 100 shares each at $151.350, $151.40, and $151.41, respectively. The price reported above reflects the average sale price.
表 I 有 2 筆交易的價格引用這則附註。
- F7
The transaction was executed in multiple trades ranging from $150.1200 to $150.1600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。